Physician

Charles Rouse Clover, M.D.

According to 2025 Medicare claims, Charles Clover, M.D. (NPI: 1518288828) practices pain management, with the plurality of this provider's patient population coming from Cleveland, NC. This provider's primary affiliated billing organization is EAST CAROLINA ANESTHESIA ASSOCIATES, PLLC (NPI: 1205996519; TIN: 201442673) and primary practice location at 28086-3362.

Clover's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 294 traditional Medicare patients, billed 1,027 HCPCS/CPT codes, and received $55,870 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 3,637 prescription claims across 657 beneficiaries totaling $131,017 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2018 DME data shows 12 claims. Open Payments data shows 44 records totaling $1,510. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	251	528	$27,981
2016	570	2,012	$110,643
2017	573	1,871	$112,040
2018	504	1,665	$99,885
2019	589	2,112	$122,232
2020	451	1,696	$104,043
2021	415	1,418	$91,558
2022	390	1,501	$93,694
2023	338	1,314	$80,138
2024	294	1,027	$55,870

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	374	997	$62,553
2016	674	5,049	$328,529
2017	663	4,077	$244,500
2018	613	3,819	$275,356
2019	709	3,906	$233,197
2020	619	3,570	$171,516
2021	661	3,502	$149,195
2022	660	3,500	$132,112
2023	694	3,561	$154,366
2024	657	3,637	$131,017

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	12	12	$12,325
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	54	95	$64
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	80	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	131	173	$42
20610	Aspiration and/or injection of fluid from large joint	64	128	$29
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	81	95	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	948	27,379	$23,504
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	693	20,463	$20,649
Xtampza Er	Oxycodone Myristate	26	778	$14,388
Nucynta	Tapentadol Hcl	11	330	$7,972
Oxycontin	Oxycodone Hcl	11	326	$5,358

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,510	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Rouse Clover, M.D.?

Tedicare shows public-source Medicare data for Charles Rouse Clover, M.D. (NPI 1518288828), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Rouse Clover, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles Rouse Clover, M.D.?

Charles Rouse Clover, M.D. is linked to EAST CAROLINA ANESTHESIA ASSOCIATES, PLLC (billing NPI 1205996519) in the available physician profile data.

Does Charles Rouse Clover, M.D. have Open Payments data?

Charles Rouse Clover, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.